Symptomatic Cerebral Infarction

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Symptomatic Cerebral Infarction trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05899582

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

The CMOSS-2 trial is a government-funded, prospective, multicenter, randomized controlled trial. It will recruit symptomatic chronic occlusion of the middle cer…

China420 participantsStarted 2023-09-15

Treatment: Extracranial-Intracranial Bypass Surgery, Medical treatment alone

All recent trials (20 shown)

Not Yet RecruitingNot Applicable

NCT07556887

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Narrowing of the carotid artery due to atherosclerosis with an unstable plaque can cause a stroke. Patients with carotid artery disease who have had a TIA or mi…

Netherlands613 participantsStarted 2026-03-31

Treatment: IMPROVE Risk Model

Active — Not RecruitingNot Applicable

NCT05491980

Florida Cerebrovascular Disease Biorepository and Genomics Center

The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting med…

United States72 participantsStarted 2022-08-02

Symptomatic Cerebral Infarction

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

All recent trials (20 shown)

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Florida Cerebrovascular Disease Biorepository and Genomics Center

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

All recent trials (20 shown)

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Florida Cerebrovascular Disease Biorepository and Genomics Center

Evaluate the Frequency of Fatigue After Cerebral Infarction

Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

DEB for Symptomatic Intracranial Atherosclerosis Stenosis

SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy

Association Between the Composition of the Bacterial Flora of Thrombi and the Etiological Origin of Cerebral Infarction…

Rescue Intracranial Stenting in Acute Ischemic Stroke

SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry

Comparison of Carbon Dioxide and Saline Flush to Saline Flush in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia

Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism

Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis

Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion

Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting

Carotid Revascularization Endarterectomy Versus Stenting Trial

SONOlysis in Prevention of Brain Infarctions dUring Carotid Stenting and caroTid EndaRterectomy

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Aspirin Or Warfarin To Prevent Stroke